11-02-2011: Protagen AG and Charles River Laboratories International, Inc. are announce a strategic Marketing & Sales alliance.

For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles River BPS delivers client-focused solutions tailored to the specific testing and manufacturing requirements of biologics. Partnering with Protagen AG, an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis, will provide clients with services covering the entire range of protein analytics from detailed protein characterization to stability and lot release testing.

Working together, Charles River and Protagen can offer analytical experience and superior services through a single point of contact, providing more efficient project work and study design.

“The technology portfolio and the exceptional expertise of Charles River in the area of certified bioservices will synergistically complement the experience and competences of Protagen in the field of biotherapeutics and biosimilars. The customers in the pharmaceutical and biotech sector will profit from this alliance through the direct access to a comprehensive service portfolio“, comments Dr. Stefan Müllner, CEO of Protagen AG.

Contact / Request information

Request further information free of charge:

Facts, background information, dossiers
More about Protagen
  • News

    Protagen and Charles River Form Strategic Partnership

    Protagen AG and Charles River Laboratories International, Inc. are announce a strategic Marketing & Sales alliance. For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles R ... more

    Protagen AG and MicroDiscovery GmbH cooperate in biomarker development

    Dortmund based Protagen AG and MicroDiscovery GmbH, a bioinformatics company based in Berlin, have started a cooperation to identify and validate biomarkers for medically relevant diseases. „Our proprietary technology platform UNIarray® and MicroDiscovery’s certified software solutions for ... more

    Protagen Deepens Cooperation With Bayer Schering Pharma

    Protagen AG and Bayer Schering Pharma AG announced the closing of a cooperation contract for discovery of novel biomarkers in Endometriosis. Endometriosis is a debilitating gynecological medical condition occuring in roughly 5% -10% of women worldwide. The golden standard of diagnosis is c ... more

More about Charles River
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE